TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Reata Pharmaceuticals, Inc. (NASDAQ: RETA) Investor Securities Class Action Lawsuit 10/15/2020

  • If you purchased shares of Reata Pharmaceuticals, Inc. (NASDAQ: RETA), you may have certain options. Please contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Lawsuit Overview

October 15, 2020 - An investor in shares of Reata Pharmaceuticals, Inc. (NASDAQ: RETA) filed a lawsuit in the U.S. District Court for the Eastern District of Texas over alleged violations of Federal Securities Laws by Reata Pharmaceuticals, Inc. in connection with certain allegedly false and misleading statements made between October 15, 2019 and August 7, 2020. Plano, TX based Reata...



You must register (for free) or login to view the entire case.

Click here to Sign In or Register (for a free account)

@screen width:
@theme:
@breakpoints:
@layout: